Connecting the clues: Diagnosing neuroendocrine tumors

Based on market research, it is estimated that roughly half of patients with NETs visit a gastroenterologist early on in their disease.1

See Full Screen Version

Consider: NETs may remain clinically silent for years. Once they do present, their symptoms can be as nonspecific as flushing, diarrhea, hypoglycemia, and abdominal cramping.2 If these are the only breadcrumbs neuroendocrine tumors leave on their limited trail, is it any wonder they are such a challenge to diagnose?

Finding and evaluating NETs

Learn more about the challenges in identifying such an elusive cancer, as well as appropriate screening choices that may help identify a NET—in some cases, even in the absence of a secretory syndrome.2 There is also a recap of key points to share with your patients regarding the diagnostic process for NETs.

Learn

Expert Point of View

Watch videos and read insights from leading physicians about best practices for managing patients with NETs.

VIEW

A Multidisciplinary Approach

Multidisciplinary Approach

"...the many treatments that are out there...really involve more than one decision by one specialty. It really involves
an integration."

DISCOVER
 

Request a NET Specialist

Continue the conversation about neuroendocrine tumors and diagnosis at your convenience.

More
 
1. Data on file. East Hanover, NJ: Novartis Pharmaceuticals Corporation; 2010.
2. Mamikunian G, Vinik AI, O'Dorisio TM, Woltering EA, Go VLW. Diagnosing and treating gastroenteropancreatic tumors, including ICD-9 codes. In: Neuroendocrine Tumors: A Comprehensive Guide to Diagnosis and Management. 4th ed. Inglewood, CA: Inter Science Institute; 2009:1-43.